Stress-induced VIPergic activation mediates microbiota/Th17cell-dependent depressive-like behaviors

•VIPergic promotion of depressive-like behaviors is dependent on the microbiome.•VIPergic activation increases SFB and hippocampal Th17 cells.•VIPergic activation induces IL-17A-mediated increase of hippocampal microglia. Chronic stress often has deleterious effects leading to the development of psy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain, behavior, and immunity Jg. 123; S. 739 - 751
Hauptverfasser: Medina-Rodriguez, Eva M., Han, Dongmei, Zeltzer, Shanie E., Moraskie Alvarez-Tabío, Michael P., O’Connor, Gregory, Daunert, Sylvia, Beurel, Eléonore
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Netherlands Elsevier Inc 01.01.2025
Schlagworte:
ISSN:0889-1591, 1090-2139, 1090-2139
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•VIPergic promotion of depressive-like behaviors is dependent on the microbiome.•VIPergic activation increases SFB and hippocampal Th17 cells.•VIPergic activation induces IL-17A-mediated increase of hippocampal microglia. Chronic stress often has deleterious effects leading to the development of psychiatric diseases. The gut-brain axis represents a novel avenue for stress research. The negative effects of stress on the gut physiology have been well-described, whereas the pathways whereby stress controls microbial composition to modulate behaviors remains mainly unknown. We discovered that vasoactive intestinal peptide (VIP) activation promoted stress-induced microbial changes leading to increased infiltration of T helper (Th) 17 cells and microglial activation in the hippocampus and depressive-like behaviors, uncovering a close crosstalk between intestinal VIPergic release and the gut microbiota during stress and providing a new interaction between the nervous system and the gut microbiome after stress. Neutralization of the signature cytokine of Th17 cells, interleukin (IL)-17A, was sufficient to block depressive-like behaviors, reduce neuronal VIPergic activation and microglia activation induced by VIPergic activation after stress, opening new potential therapeutic targets for depression.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
EB planned the study. EB, EMMR and DH performed and analyzed the experiments. MPM, GO, and SD assisted with bacteria experiments and manuscript revisions. EB wrote the manuscript.
Author contributions
ISSN:0889-1591
1090-2139
1090-2139
DOI:10.1016/j.bbi.2024.10.016